Human Papillomavirus Vaccination Beyond Age 26: Evidence, Limitations, And Implications For Vaccination Policy

Joe Lebbos, Pierre Kassis, Carolina Navas, Rita Nahle, Jacques Choucair, Akel Azzi, Faculty of Medicine, Saint-Joseph University, School of Political Studies, Faculty of Social Sciences, University of Ottawa, Department of Public Health Sciences, Queens University, Department of Infectious Diseases, Hôtel Dieu de France, Saint Joseph University of Beirut

Journal of Primary Care & Community Health

Published online on May 20, 2026

Abstract

Journal of Primary Care & Community Health, Volume 17, January-December 2026.
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection globally and a major cause of anogenital and oropharyngeal cancers. Prophylactic HPV vaccination is most effective when administered before sexual debut and is routinely ...